Ontology highlight
ABSTRACT: Controls
The novel classical CS inhibitor, Peptide Inhibitor of Complement C1 (PIC1) reduced inflammation when added directly or saturated in an acellular skin scaffold, as reflected by reduced CS components and leukocyte infiltration. A significant increase in expression of STAT4 and the downstream macrophage chemokine CCL2 and its receptor CCR2 were also found in the early wounds of db/db mice compared to non-diabetic controls. These studies provide evidence for two new promising targets to reduce unresolved inflammation and to improve healing of diabetic skin wounds.
SUBMITTER: Cunnion KM
PROVIDER: S-EPMC5249255 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
Cunnion Kenji M KM Krishna Neel K NK Pallera Haree K HK Pineros-Fernandez Angela A Rivera Magdielis Gregory MG Hair Pamela S PS Lassiter Brittany P BP Huyck Ryan R Clements Mary A MA Hood Antoinette F AF Rodeheaver George T GT Cottler Patrick S PS Nadler Jerry L JL Dobrian Anca D AD
PloS one 20170120 1
Diabetic non-healing wounds are a major clinical problem. The mechanisms leading to poor wound healing in diabetes are multifactorial but unresolved inflammation may be a major contributing factor. The complement system (CS) is the most potent inflammatory cascade in humans and contributes to poor wound healing in animal models. Signal transducer and activator of transcription 4 (STAT4) is a transcription factor expressed in immune and adipose cells and contributes to upregulation of some inflam ...[more]